In 2014, the Iowa legislature passed SF 2360, the “Medical Cannabidiol Act,” which allows licensed neurologists to certify patients with intractable epilepsy to use cannabidiol (CBD) products with 3% or less THC content. The law does not allow other types of physicians to write qualifying recommendations, nor does it allow for patients with any other conditions to obtain legal protections. Qualifying patients must obtain a state registry ID card in order to receive legal protection; qualifying patients may designate a caregiver to assist them. The law does not impose a minimum amount of CBD, but does not extend legal protections for products with more than 3% THC. The state began issuing registration ID cards to qualifying patients in 2015, but patients have no ability to purchase or cultivate their medicine in state.
Law
Regulations
Administrative Rules (2015)
Share this page
